Dristan Long Lasting

Quick links

Choose a section

Quick links to important sections

Advertisements

Dristan Long Lasting

Advertisements

Overview of Dristan Long Lasting

Property Description
Active ingredient Oxymetazoline Hydrochloride
Form Nasal spray / Nasal solution
Pharmacological class Sympathomimetic Amine / Adrenergic Agent
General purpose Relief of nasal and sinus congestion
Origin Synthetic (Imidazoline derivative)

Dristan Long Lasting: Type and Classification

Dristan Long Lasting is an over-the-counter (OTC) nasal preparation and a direct-acting adrenergic agent used to temporarily relieve congestion. Pharmacologically, it is classified as a Sympathomimetic amine and is structurally identified as a synthetic Imidazoline derivative. This classification indicates the medicine's ability to selectively stimulate receptors within the nasal lining. Its most distinguishing feature is its long-acting duration, which provides sustained functional relief from congestion for prolonged periods.

Composition, Form, and Topical Administration

This medicine is a single-entity product, containing Oxymetazoline Hydrochloride as its sole active pharmaceutical ingredient. The product is formulated as an aqueous solution delivered via a nasal spray or nasal solution for topical administration. This targeted delivery ensures the drug's effects are concentrated directly on the nasal mucous membranes, focusing the therapeutic action precisely where the swelling occurs.

General Purpose and Physiological Effect

The general purpose of using this medicine is to quickly clear the nasal airways by reducing tissue swelling. Oxymetazoline achieves this by initiating local vasoconstriction—the narrowing of the blood vessels—within the nasal lining. This physiological action rapidly mitigates the excessive blood flow (hyperemia), leading to the effective shrinkage of swollen nasal mucous membranes. This process restores the opening of the nasal passages, relieving the sensation of physical obstruction.

Advertisements

What side effects are possible with Dristan Long Lasting?

Possible side effects and safety information

The safety profile for oxymetazoline hydrochloride is classified by the nature of the effects—distinguishing between generally temporary local reactions and less common systemic adverse reactions. Safety classifications are based on official regulatory documents, which group effects by frequency and the body system affected.

Adverse Reactions by Frequency and Organ System

Adverse reactions that manifest directly at the application site are generally classified as uncommon (occurring in fewer than 1 in 100 people). These may include temporary discomfort such as sneezing, dryness, or irritation in the nose, mouth, or throat. Local effects such as burning and stinging may also occur as temporary discomfort upon application.

Systemic effects are generally classified as rare (occurring in fewer than 1 in 1,000 people) and involve organ systems beyond the nasal passages. Rare reactions include those related to Vascular disorders and Cardiac disorders (such as increased blood pressure, tachycardia, or palpitations) and Nervous system disorders (such as anxiety, irritability, or headache).

Duration-Related and Population Safety Notes

A critical safety constraint explicitly documented in regulatory labeling relates to the effect of prolonged exposure. Rhinitis medicamentosa, or the recurrence and worsening of nasal congestion (rebound congestion), is a safety pattern associated with frequent or prolonged use beyond the recommended duration.

Population-specific safety notes advise particular caution for certain groups. Children may be particularly susceptible to systemic absorption and the subsequent adverse effects. For women who are pregnant or breastfeeding, caution is advised because the substance may be absorbed systemically, though it is unknown whether it is excreted into breast milk.

Regulatory documents also detail that severe systemic absorption, most often associated with overdose, can lead to clinically significant events such as cardiac arrhythmia and cardiac arrest.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Oxymetazoline Hydrochloride (Dristan Long Lasting) is defined by the risk of systemic absorption, which can occur following the inadvertent or accidental ingestion of the nasal solution. This exposure can lead to severe and life-threatening toxicity, particularly in young children.

Overdose presentations documented in regulatory labeling include pronounced central nervous system (CNS) effects such as somnolence, sedation, lethargy, and loss of consciousness, potentially advancing to coma. Cardiovascular manifestations are also officially described, including hypertension, cardiac arrhythmia, bradycardia, and shock-like hypotension, which may progress to cardiac arrest. Other documented symptoms include mydriasis, cyanosis, nausea, vomiting, and convulsions.

Due to the potential for severe, life-threatening outcomes, including apnoea and cardiovascular failure, the official labeling mandates immediate action. No specific neutralizing antidote is documented. Seek emergency medical care immediately for any suspected overdose or accidental ingestion. In particular, the FDA and other government bodies advise contacting the Poison Help Line (1-800-222-1222) immediately following accidental ingestion by a child, as even small amounts (1–2 mL) have been associated with serious events in children 5 years of age and younger. Management described in regulatory documents is symptomatic and supportive, requiring hospital monitoring of vital signs and neurological status.

Advertisements

Therapeutic Uses of Dristan Long Lasting

What Dristan Long Lasting Treats: Main Uses and Benefits

This medication is commonly used to relieve nasal discomfort and congestion associated with specific conditions. It is applied when symptom clusters may become intense or disruptive, providing support that helps ease the overall symptom burden.


Symptom Relief and Clinical Use

This medication is relevant across domains where short-term symptomatic assistance is needed, being commonly used across conditions presenting with acute episodes, such as respiratory infections and allergic manifestations. It helps manage symptoms that interfere with daily functioning, such as pronounced physical obstruction and sinus pressure. The primary therapeutic benefit helps improve day-to-day comfort and provides supportive relief when symptoms create noticeable physiological strain.

“The long-duration benefit offers symptomatic relief that may assist with maintaining a sense of stability when symptoms are more noticeable.”

The medication is commonly used during phases when symptoms become more noticeable, offering additional symptomatic assistance for temporary nasal blockage.

Quick Fact: Relief for Acute Nasal Obstruction
Primary Focus: Management of nasal stuffiness and congestion.
Duration Benefit: The long-duration benefit supports symptom management for extended periods.

Relief from Allergic Nasal Blockage

When symptoms are caused by allergies, the medication is applied in addressing the nasal blockage associated with irritation. The supportive relief provided assists with maintaining functional stability and contributes to easing the overall symptom load during difficult episodes of allergic manifestations.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

The eligibility for using Dristan Long Lasting (Oxymetazoline Hydrochloride) is determined by regulatory agencies based on age, pre-existing health conditions, and drug sensitivities, as outlined in official labeling. Use is strictly prohibited for certain populations, while others require professional consultation.


Eligibility and Non-Eligibility Status

Classification Status as Defined in Regulatory Documents
Approved Age Groups Adults and Children 12 years and older are generally permitted [1.2, 2.8]. Use in children 6 to under 12 years may be permitted with adult supervision [1.1, 2.4].
Absolute Contraindications Patients with known Hypersensitivity to Oxymetazoline or any product component [1.2]. Use is also contraindicated in those with Narrow-Angle Glaucoma, Rhinitis Sicca, or following specific cranial surgeries [1.2].
Conditional Restrictions Patients with Heart Disease, High Blood Pressure, Diabetes, Thyroid Disease, or Prostatic Enlargement are subject to restrictions and are advised to consult a health professional before use [1.1, 2.4].
Age Restriction The product is Not Recommended or Contraindicated for children under 6 years of age for the standard strength [1.2, 2.1].
Physiological Status Individuals who are Pregnant or Breastfeeding must Ask a Health Professional Before Use [1.1, 2.4].
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interaction patterns for Oxymetazoline Hydrochloride (Dristan Long Lasting) as described in regulatory documentation.

Contraindicated Combinations and Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated due to the risk of a severe hypertensive reaction. This restriction requires a mandatory time separation: the nasal spray must not be used for up to 14 days after stopping MAOI therapy. This restriction is based on the pharmacodynamic effect where MAOIs can amplify the vasoconstrictive action of Oxymetazoline.


Pharmacodynamic Interaction Patterns

The medicine's sympathomimetic activity underlies documented interactions with several drug classes, leading to additive or opposing effects:

Interacting Product Category Officially Documented Interaction Outcome
Tricyclic Antidepressants (TCAs) Possible increased risk of hypertension and cardiac arrhythmias.
Other Sympathomimetics Risk of additive cardiovascular toxicity, such as increased blood pressure.
Antihypertensive Agents (e.g., Beta-blockers) Potential antagonism (reduction) of the antihypertensive drug's effectiveness.

Additionally, official labeling notes that concomitant use of this medicine with certain other intranasal products should be avoided, as an administration-timing interaction may reduce the exposure or effect of the co-administered intranasal product.

Advertisements

Mechanism of Action

Targeted alpha-Adrenergic Receptor Agonism

The action of the active molecule, Oxymetazoline, is established by its role as a direct-acting agonist that primarily activates post-junctional alpha1-adrenergic receptors (alpha1-AR) located on the smooth muscle of blood vessels in the nasal lining. This interaction mimics the body's natural sympathetic response, engaging a molecular cascade that leads to the contraction of the local vascular smooth muscle.

Vasoconstriction and Reversal of Tissue Fluid

The activation of alpha1-AR initiates the vasoconstriction of the nasal arterioles and venules, which initiates a reduction in the excessive blood flow (hyperemia) to the area. This physiological effect reduces the blood volume within the nasal submucosa, thereby decreasing capillary pressure and facilitating the reabsorption of tissue fluid (edema). The mechanistic consequence is the physiological shrinkage (detumescence) of the nasal mucous membranes.

Mechanism Constraints: Tachyphylaxis and Receptor Dynamics

This alpha-agonist mechanism is subject to constraints, including receptor desensitization and downregulation upon prolonged or frequent use. This adaptive change in the receptor system leads to tachyphylaxis (a rapidly diminishing effect) and underlies the potential for rebound congestion upon withdrawal, a state caused by chronic stimulation leading to reactive vasodilation.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Dristan Long Lasting (Oxymetazoline Hydrochloride)

Dristan Long Lasting is an intranasal spray, administered into the nose for local effect, and must be used strictly as directed to prevent misuse. The standard procedure for administration involves keeping the head upright, inserting the nozzle into one nostril while pressing the other closed, and squeezing the bottle quickly and firmly while sniffing gently. After use, the nozzle should be wiped clean.

Age Group Dosage and Frequency (Do not exceed) Special Conditions
Adults and Children 6 to under 12 years 2 to 3 sprays in each nostril every 10 to 12 hours Max 2 doses in any 24-hour period; Adult supervision required for children.
Children under 6 years Ask a doctor Safety and efficacy have not been established.

Crucially, do not use this nasal spray for more than three consecutive days. Use beyond this period may lead to rebound congestion, a condition where the nasal passages swell more severely when the medicine wears off, potentially worsening the original symptoms. If a dose is missed, it should be used as soon as remembered; however, the missed dose must be skipped if it is near the time for the next scheduled dose. Never use extra medicine to compensate for a missed dose. Prior to first use, or if the product has not been used for several days, the pump may need to be primed by depressing it firmly several times until a fine mist appears.

Advertisements

Recent Clinical Evidence

Research on Oxymetazoline Hydrochloride

Dristan Long Lasting Nasal Spray contains the active ingredient oxymetazoline hydrochloride (0.05%), which is classified as an alpha-adrenergic receptor agonist. Research studies investigate the actions of this agent in laboratory and clinical settings. The pharmacological profile is a subject of continuing research.

Efficacy and Duration

Clinical trials have evaluated the effect of 0.05% oxymetazoline on nasal congestion associated with conditions such as the common cold, hay fever, and other upper respiratory allergies.

  • Relief of Congestion: A pooled analysis of randomized, double-blind, vehicle-controlled clinical studies in patients with acute rhinitis reported changes in both subjective nasal congestion scores and objective measures of nasal airflow (nasal patency).
  • Duration of Effect: Objective measures of nasal flow were statistically significant up to 12 hours following a single dose. This finding supports the claim of long-lasting action compared to a vehicle (placebo).

Tolerability and Prolonged Use

The tolerability of oxymetazoline has been assessed in clinical trials. Studies documented various adverse events, with common reports including burning, stinging, or dryness inside the nose, and sneezing. Serious adverse events were observed infrequently in trial participants.

  • Rhinitis Medicamentosa: Prolonged and excessive use of topical decongestants, including oxymetazoline, is associated with the potential for rebound nasal congestion, or rhinitis medicamentosa, which may result in increased nasal blockage.
  • Long-Term Research: Current guidelines typically advise short-term use, though some research has examined the effects of oxymetazoline use for periods up to four weeks in normal subjects. Further research is examining the effects of the drug over the long term, beyond the initial trial periods.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dristan Long Lasting (FAQ)


Q: Does Dristan Long Lasting only work on nasal congestion?

According to official product labeling, this medication is indicated for the temporary relief of both nasal congestion and associated sinus congestion and pressure. This relief is intended for symptoms caused by conditions such as the common cold, hay fever, or other respiratory allergies.


Q: What kind of nasal irritation or dryness is listed as a potential side effect?

Official safety documents mention that local effects may occur temporarily upon administration. These include dryness, burning, or stinging inside the nose, as well as sneezing. Such discomfort is generally classified as an uncommon local reaction.


Q: Is it typical to experience a burning or stinging sensation immediately after using Dristan Long Lasting?

Official sources describe a temporary discomfort such as burning or stinging inside the nose as a possible, but non-serious, local effect. This initial sensation is generally noted to be short-lived.


Q: Can Dristan Long Lasting be used by individuals with diabetes?

Official labeling indicates that individuals with diabetes are subject to restrictions and are advised to consult a health professional before use. This caution is in place because the medicine's sympathomimetic activity carries a slight potential for systemic absorption, which may affect underlying conditions.


Q: Is it okay to use this spray at the same time as a prescription allergy pill?

Regulatory documents warn against combining this spray with certain medicines that affect the cardiovascular system, such as other sympathomimetics (decongestants) or specific antidepressants like MAOIs and TCAs. Since official product information does not address every possible combination, information about combinations is best reviewed with a health professional.


Q: Does Dristan Long Lasting interact with common cold and flu medications?

Official documents warn against using this spray with other sympathomimetics because of the risk of additive cardiovascular toxicity, such as increased blood pressure, a category into which some cold and flu medicines fall.


Q: What are general expectations for results after a few days of use?

The product is explicitly labeled for temporary relief and is designed for use no longer than three consecutive days. Prolonged or frequent use beyond this period is associated with tachyphylaxis, meaning the effect rapidly diminishes, and may lead to rebound congestion.


Q: How long does the "long lasting" effect typically last?

Based on the dosing schedule and clinical studies, the product is labeled to provide relief for up to 12 hours. Regulatory directions advise using the medication no more often than every 10 to 12 hours.


Q: Is the medication intended for use in chronic or only acute congestion?

The official label describes the product for the temporary relief of congestion due to acute conditions like the common cold and allergies. The strong warning against using it for more than three consecutive days further reinforces its intended use for short-term, acute symptoms.


Q: Is it necessary to shake the bottle before using Dristan Long Lasting?

Official product labeling for some formulations states that the bottle should be shaken well before use to ensure proper mixture and delivery. It is also recommended that the pump be primed prior to first use, or if the product has not been used for several days.


Q: Is this medication available as a tablet or only as a spray?

The official drug product (Dristan Long Lasting) is designed for topical administration as an aqueous nasal spray or nasal solution. This is intended to concentrate the therapeutic effect directly on the nasal lining, achieving localized relief.


Q: Is there any known difference between the spray format and the drops format?

The primary difference is primarily in the administration method described in regulatory instructions. The spray is typically administered with the head upright, while the drops format may require tilting the head back to allow the medicine to spread in the nasal passage.


Q: What should I expect if I miss using a treatment?

Official administration guidelines advise that if a dose is missed, it should be skipped if it is near the time for the next scheduled dose. Regulatory guidance advises against using extra medicine to compensate for a missed dose.


Q: Are there any reported side effects related to sleep?

Official documents list trouble in sleeping (insomnia) as a potential systemic side effect. While generally rare, this is acknowledged in the safety profile related to the medicine's activity on the central nervous system.


Q: Is there a connection between Dristan Long Lasting and nosebleeds?

Common side effects include local dryness and irritation of the nose, which may sometimes lead to nasal bleeding. However, official safety classifications do not explicitly list nosebleeds (epistaxis) as a common or uncommon adverse reaction for the standard product.


Q: Can the spray be used if someone has recently had surgery on their nose or sinuses?

Official contraindications include use following specific cranial surgeries. This means that use following recent nasal or sinus surgery is a consideration best reviewed with a health professional.


Q: What is the official guidance on using this spray while pregnant?

The official label advises: "If pregnant or breast-feeding, ask a health professional before use." This caution is based on the potential for the substance to be systemically absorbed, though the safety profile is not fully established for these populations.


Q: Does official information clarify how to minimize the potential for rebound effects?

The primary method regulatory documents provide to avoid or minimize the potential for rebound congestion is by strictly observing the warning that the product should not be used for more than three consecutive days. This limitation prevents the adaptive changes that lead to the condition.


Q: Is Dristan Long Lasting available in a preservative-free version?

The standard product formulation lists benzalkonium chloride solution as an inactive ingredient (a preservative). Official regulatory documents for the standard product do not explicitly confirm the availability of a specific preservative-free version.


Q: What is the official guidance on accidentally swallowing a small amount of the spray?

Official labeling provides an emergency warning for accidental swallowing of the product, advising immediate contact with a Poison Control Center or medical help. This warning is based on the risk of systemic absorption if a large amount were swallowed.


Q: Is there any information on how the product should be disposed of?

Official regulatory labeling for the product does not provide specific instructions for the household disposal of unused or expired nasal spray. Official guidance indicates that disposal must follow local municipal guidelines.

Advertisements

How should Dristan Long Lasting be stored and disposed of?

Storage and Disposal Requirements

Dristan Long Lasting Nasal Spray must be stored under specific environmental and safety conditions as defined by regulatory labeling.

Official Storage Conditions

Storage Requirement Specification
Temperature Store at controlled room temperature, 20–25°C (68–77°F).
Freezing Protect from freezing. Do not store the medicine in a freezer.
Packaging Retain the original carton for access to the complete product labeling.

Child Safety and Handling

This medicine must be stored out of reach of children. If the product is accidentally swallowed, immediate medical assistance is required; the label instructs users to contact a Poison Control Center or seek emergency medical help right away. The official regulatory labeling does not provide specific instructions for the household disposal of unused or expired nasal spray; disposal should comply with local municipal guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dristan Long Lasting found in:

A-Z Index: